e-learning
resources
Berlin 2008
Tuesday, 07.10.2008
Therapy of thoracic tumours
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Systemic inflamatory reaction following pleurodesis with talk surray
M. Lerikou, G. Antoniou, D. Hajhilia, M. Zontanos, G. Pavlakou, P. Demertzis, O. Anagnostopoulou (Athens, Greece)
Source:
Annual Congress 2008 - Therapy of thoracic tumours
Session:
Therapy of thoracic tumours
Session type:
E-Communication Session
Number:
4304
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Lerikou, G. Antoniou, D. Hajhilia, M. Zontanos, G. Pavlakou, P. Demertzis, O. Anagnostopoulou (Athens, Greece). Systemic inflamatory reaction following pleurodesis with talk surray. Eur Respir J 2008; 32: Suppl. 52, 4304
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Dutch Pneumothorax Study: analogue versus digital drainage in PSP, a randomized trial
Malignant pleural effusion management: is combining pleurodesis techniques the way forward? Results of the IPC-PLUS trial.
NSCLC/SCLC diagnosis and staging of thoracic tumours
Related content which might interest you:
Talc poudrage during thoracoscopy induces fever and systemic inflammatory reaction
Source: Eur Respir J 2005; 26: Suppl. 49, 317s
Year: 2005
Systemic inflammatory reactions in COPD patients
Source: Eur Respir J 2006; 28: Suppl. 50, 38s
Year: 2006
Systemic inflammatory repercussions after pleurodesis in an experimental model of pneumothorax
Source: Annual Congress 2013 –Chest wall and pleura
Year: 2013
Systemic treatment
Source: European Multidisciplinary Conference in Thoracic Oncology 2009
Year: 2009
Evidence that mesothelial cells regulate the acute inflammatory response in talc pleurodesis
Source: Eur Respir J 2006; 28: 929-932
Year: 2006
Systemic lupus erythematosus-associated PAH: is targeting inflammation the key to success?
Source: Eur Respir Rev 2011; 20: 218-219
Year: 2011
Systemic manifestations of sarcoidosis
Source: Eur Respir J 2006; 28: Suppl. 50, 95s
Year: 2006
Acute inflammatory response secondary to intrapleural administration of two types of talc
Source: Eur Respir J 2010; 35: 396-401
Year: 2010
Are there any predictors of MTX response in progressive pulmonary sarcoidosis?
Source: International Congress 2015 – Acute and chronic lung diseases: good clinical practice
Year: 2015
Granulomatous reaction in a patient with lung cancer: should we treat it?
Source: Breathe, 14 (3) e94; 10.1183/20734735.014617
Year: 2018
Systemic inflammation in OSA
Source: Annual Congress 2009 - PG21 Morbidity and mortality of sleep-disordered breathing: jointly organised with ACCP
Year: 2009
Short-term respiratory and systemic inflammatory responses to welding exposure
Source: International Congress 2015 – Occupational disease: clinical cases and series
Year: 2015
Non specific interstitial pneumonia in systemic sclerosis and idiopathic interstitial pneumonia: repair or remodeling process?
Source: Annual Congress 2007 - Pathogenesis of idiopathic interstitial pneumonia including idiopathic pulmonary fibrosis
Year: 2007
The neutrophilic and fibrinolytic response to talc can predict the outcome of pleurodesis
Source: Eur Respir J 2006; 27: 817-821
Year: 2006
Systemic treatment: an adjuvant indication?
Source: Annual Congress 2004 - Lung metastases
Year: 2004
Improvement in SARS-CoV2 lung interstitial injuries with systemic corticosteroid treatment
Source: Virtual Congress 2021 – Interstitial lung disease, COVID-19 and friends
Year: 2021
Interstitial lung disease in systemic sclerosis: where do we stand?
Source: Eur Respir Rev 2015; 24: 411-419
Year: 2015
Molecular-cellular features of macrophage reaction in granulomatous pulmonary diseases
Source: Annual Congress 2007 - Novel mediators of cellular pathology
Year: 2007
Clinical perspective and practices on pleural effusions in chronic systemic inflammatory diseases
Source: Breathe, 16 (4) 200203; 10.1183/20734735.0203-2020
Year: 2020
Importance of concomitant local and systemic eosinophilia in uncontrolled asthma
Source: Eur Respir J 2014; 44: 1096-1098
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept